171 related articles for article (PubMed ID: 33229194)
1. Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer's disease: A hypothesis.
Olsen I; Singhrao SK
Med Hypotheses; 2021 Jan; 146():110393. PubMed ID: 33229194
[TBL] [Abstract][Full Text] [Related]
2. Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
González-Sánchez M; Bartolome F; Antequera D; Puertas-Martín V; González P; Gómez-Grande A; Llamas-Velasco S; Herrero-San Martín A; Pérez-Martínez D; Villarejo-Galende A; Atienza M; Palomar-Bonet M; Cantero JL; Perry G; Orive G; Ibañez B; Bueno H; Fuster V; Carro E
EBioMedicine; 2020 Jul; 57():102834. PubMed ID: 32586758
[TBL] [Abstract][Full Text] [Related]
3. The role of microbiome-host interactions in the development of Alzheimer´s disease.
Weber C; Dilthey A; Finzer P
Front Cell Infect Microbiol; 2023; 13():1151021. PubMed ID: 37333848
[TBL] [Abstract][Full Text] [Related]
4. Salivary Lactoferrin Expression in a Mouse Model of Alzheimer's Disease.
Antequera D; Moneo D; Carrero L; Bartolome F; Ferrer I; Proctor G; Carro E
Front Immunol; 2021; 12():749468. PubMed ID: 34659251
[TBL] [Abstract][Full Text] [Related]
5. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions.
Bermejo-Pareja F; Del Ser T; Valentí M; de la Fuente M; Bartolome F; Carro E
Alzheimers Dement; 2020 Aug; 16(8):1196-1204. PubMed ID: 32543760
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
Nara PL; Sindelar D; Penn MS; Potempa J; Griffin WST
J Alzheimers Dis; 2021; 82(4):1417-1450. PubMed ID: 34275903
[TBL] [Abstract][Full Text] [Related]
7. Dietary Lactoferrin Supplementation Prevents Memory Impairment and Reduces Amyloid-β Generation in J20 Mice.
Abdelhamid M; Jung CG; Zhou C; Abdullah M; Nakano M; Wakabayashi H; Abe F; Michikawa M
J Alzheimers Dis; 2020; 74(1):245-259. PubMed ID: 31985470
[TBL] [Abstract][Full Text] [Related]
8. Agglutination of Streptococcus mutans serotype C cells but inhibition of Porphyromonas gingivalis autoaggregation by human lactoferrin.
Soukka T; Tenovuo J; Rundegren J
Arch Oral Biol; 1993 Mar; 38(3):227-32. PubMed ID: 8387771
[TBL] [Abstract][Full Text] [Related]
9. The effect of lactoferrin on oral bacterial attachment.
Arslan SY; Leung KP; Wu CD
Oral Microbiol Immunol; 2009 Oct; 24(5):411-6. PubMed ID: 19702956
[TBL] [Abstract][Full Text] [Related]
10. Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease.
Bartolome F; Orive G; Carro E
Alzheimers Dement (Amst); 2021; 13(1):e12173. PubMed ID: 33969170
[TBL] [Abstract][Full Text] [Related]
11. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin levels in gingival crevicular fluid and saliva of HIV-infected patients with chronic periodontitis.
Ferreira SM; Gonçalves LS; Torres SR; Nogueira SA; Meiller TF
J Investig Clin Dent; 2015 Feb; 6(1):16-24. PubMed ID: 25331852
[TBL] [Abstract][Full Text] [Related]
13. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
14. The role of natural salivary defences in maintaining a healthy oral microbiota.
Lynge Pedersen AM; Belstrøm D
J Dent; 2019 Jan; 80 Suppl 1():S3-S12. PubMed ID: 30696553
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin of oral fluid is normal and in Alzheimer's disease: laboratory and diagnostic aspects (review of literature).
Bazarnyi VV; Sidenkova AP; Sosnin DY
Klin Lab Diagn; 2022 Apr; 67(4):207-212. PubMed ID: 35575393
[TBL] [Abstract][Full Text] [Related]
16. Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis.
Nijakowski K; Owecki W; Jankowski J; Surdacka A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256241
[TBL] [Abstract][Full Text] [Related]
17. A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway.
Mohamed WA; Salama RM; Schaalan MF
Biomed Pharmacother; 2019 Mar; 111():714-723. PubMed ID: 30611996
[TBL] [Abstract][Full Text] [Related]
18. Oral microbiota and Alzheimer's disease: Do all roads lead to Rome?
Sureda A; Daglia M; Argüelles Castilla S; Sanadgol N; Fazel Nabavi S; Khan H; Belwal T; Jeandet P; Marchese A; Pistollato F; Forbes-Hernandez T; Battino M; Berindan-Neagoe I; D'Onofrio G; Nabavi SM
Pharmacol Res; 2020 Jan; 151():104582. PubMed ID: 31794871
[TBL] [Abstract][Full Text] [Related]
19. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.
Bartolomé F; Rosa L; Valenti P; Lopera F; Hernández-Gallego J; Cantero JL; Orive G; Carro E
Front Immunol; 2022; 13():878201. PubMed ID: 35547737
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.
Guo C; Yang ZH; Zhang S; Chai R; Xue H; Zhang YH; Li JY; Wang ZY
Neuropsychopharmacology; 2017 Dec; 42(13):2504-2515. PubMed ID: 28079060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
